The results showed that TAZ expression was significantly elevated in bladder urothelial carcinoma (BLCA), breast invasive carcinoma, cholangiocarcinoma (CHOL), esophageal carcinoma (ESCA), head and neck cancer (HNSC), kidney renal clear cell carcinoma, kidney renal papillary cell carcinoma (KIRP), liver hepatocellular carcinoma, lung adenocarcinoma, lung squamous cell carcinoma (LUSC), prostate adenocarcinoma, stomach adenocarcinoma, thyroid carcinoma, and especially in COAD and READ (Figure 1A and Supplementary Figure 1A). This evidence concerns the gene WWTR1 and carcinoma of esophagus.